Emcure Pharmaceuticals IPO

Emcure Pharmaceuticals plans an IPO of INR 1,952.03 crores, with INR 800 crores as fresh issue and offers to sell 1.152.03 crores equity shares for debt repayment and corporate uses.

Important Details

Open Date : July 3, 2024 Close Date : July 5, 2024 Allotment Date: July 8, 2024 Listing Date: July 10, 2024

Important Details

IPO Price: INR 960-1008 per share Lot Size: 14 Shares Total Issue Size: INR 1,952.03 crores

Fundamental Analysis

Emcure Pharmaceuticals IPO analysis shows mixed performance: 1. Steady revenue growth,Declining profitability. 2. Lower EPS and RoNW. 3. Improved liquidity,Increased total assets.

Peer Comparison

Emcure Pharmaceuticals: Revenue ₹59,858.11 million,Competitive financials among peers. Abbott India: High EPS and RoNW. Dr. Reddy’s Laboratories: Strong P/E and NAV.


Emcure Pharmaceuticals Limited’s IPO aims to repay and prepay certain outstanding borrowings.

Risks And Challenges

Emcure Pharmaceuticals IPO risks: 1. Regulatory compliance. 2. Potential product recalls. 3. Supply chain disruptions. 4. Dependency on local distributors. 5. Delays in approvals affecting operations and finances.